Skip to content

Oral Propranolol for Reducing Pediatric Dental Patients Anxiety

Evaluating of Oral Propranolol Effect on Managing Anxiety of Dental Extractions in Children: A Randomized Controlled Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03388957
Enrollment
60
Registered
2018-01-03
Start date
2018-07-30
Completion date
2020-02-15
Last updated
2021-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extrusion of Tooth

Brief summary

Evaluating anxiety, heart rate and behavior during dental extractions after oral dose of either Propranolol, Midazolam or a combination of both in uncooperative pediatric patients.

Detailed description

Use of 0.5 mg/kg of Propranolol or a combination of Propranolol and Midazolam for the first time to manage uncooperative pediatric dental patients anxiety, comparing with Midazolam by evaluating anxiety, heart rate and behavior during administration of local anesthesia and extraction.

Interventions

DRUGMidazolam

This drug will be given before the extraction procedure

DRUGPropranolol

This drug will be given before the extraction procedure

Sponsors

Damascus University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Three groups, with 20 children in each group

Eligibility

Sex/Gender
ALL
Age
8 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

* High to extreme fear of tooth or molar anesthesia and removal (Frankl: Definitely negative). * Scoring more than 19 points on MCDAS(f). * Healthy pediatric patients (ASA I) aging 8-10 years. * Indication for primary tooth or molar extraction. * Fasting if indicated (severe gag reflex). * Airway assessment (Mallampati and tonsillar hypertrophy).

Exclusion criteria

* Asthma or any other obstructive pulmonary disease. * Cardiac failure. * Cardiac arrhythmia. * Renal failure. * Diabetes. * Current use of another ß-adrenoreceptor antagonist. * Current use of anxiolytic or antidepressant medication. * Currently in psychotherapy for dental anxiety. * Systolic blood pressure \<100 mmHg. * Diastolic blood pressure \<60 mmHg. * Active Upper respiratory infection.

Design outcomes

Primary

MeasureTime frameDescription
Change in Anxiety-1 levels(1) five minutes before medication, (2) 30 minutes post-extractionAnxiety-1 levels will be evaluated using self-reported faces anxiety scale (also called 'modified child dental anxiety scale). Scale name: Modified Child Dental Anxiety Scale (MCDAS): 1. Relaxed/Not worried. (Better outcome) 2. Very slightly worried. 3. Fairly worried. 4. Worried a lot. 5. Very worried. (Worse outcome)
Change in Anxiety-2 levels(1) 45 minutes after medication, while applying local anesthesia, (2) after 10 minutes of applying the anesthesia and during tooth extraction.Anxiety-2 levels will be measured using Observational Venham Anxiety Scale Major Issues: 1) Will be measured in 2 phases: * 45 minutes after medication, while applying local anesthesia. * While extracting the tooth. Venham Anxiety Scale: 0. Relaxed. (Better outcome) 1. Uneasy. 2. Tense. 3. Reluctant. 4. Interference. 5. Out of contact. (Worse outcome)
Change in heart rate(1) 5 minutes before medication, (2) 45 minutes after medication, while applying local anesthesia, (3) after 10 minutes of applying the anesthesia and during tooth extraction, (4) 30 minutes following extractionusing Finger Pulse Oximeter

Secondary

MeasureTime frameDescription
Change in Behavior(1) 45 minutes after medication, while applying local anesthesia, (2) after 10 minutes of applying the anesthesia and during tooth extractionusing Observational Frankl Scale Frankl Scale: 1. Definitely negative. (Worse outcome) 2. Negative. 3. Positive. 4. Definitely positive. (Better outcome)

Countries

Syria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026